| Financial Year |
March 31 2023 |
| Monetary Funds |
1,091,678,538.51 |
| Held-for-trading Financial Assets |
2,980,080.00 |
| Notes Receivable |
183,618,183.67 |
| Accounts Receivable |
3,750,675,695.30 |
| Advances to Suppliers |
129,563,648.50 |
| Other Receivables |
490,802,008.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
631,543,452.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
79,415,585.94 |
| Total Current Assets |
6,932,795,287.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,959,551,776.59 |
| Under-construction Projects |
1,002,638,284.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
486,572,862.06 |
| R&D expenses |
-- |
| Goodwill |
99,952,110.06 |
| Long-Term Deferred and Prepaid Expenses |
15,187,768.78 |
| Deferred Income Tax Assets |
479,640,410.96 |
| Other Non-Current Assets |
165,667,993.70 |
| Sub-Total of Non-Current Assets |
6,464,422,412.88 |
| Total Assets |
13,397,217,699.88 |
| Short-Term Loans |
1,949,068,077.65 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,469,733,520.85 |
| Accounts Payable |
3,341,364,073.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
260,071,416.72 |
| Taxes Payable |
106,303,566.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
423,404,841.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
754,803,074.59 |
| Other Current Liabilities |
55,265,619.01 |
| Sub-Total of Current Liabilities |
8,626,851,280.89 |
| Long-term Loans |
1,712,248,305.05 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
210,468,091.60 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,261,680.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,268,437,936.91 |
| Total Liabilities |
10,895,289,217.80 |
| Paid-In Capital(Or Share Stock) |
376,437,486.00 |
| Capital Surplus |
561,317,353.70 |
| Surplus Reserve |
155,947,530.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,204,700,613.81 |
| Minority Stockholder's Interest |
203,379,462.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,298,549,019.16 |
| Owner's Equity（Stockholder's Equity） |
2,501,928,482.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,397,217,699.88 |
